• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

0
  • by alexperjescuadmin
  • in Public Health
  • — 19 Jan, 2007
Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
AudioMedica News
Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-226"/>
Rodger MacArthur

RODGER MACARTHUR, Wayne State University, Detroit

REFERENCE: Lancet 2006; 368: 2125-35
A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST study had three arms which included non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), or both, all in the presence of nucleoside reverse transcriptase inhibitors. Derek Thorne heard more from Rodger MacArthur of Wayne State University in Detroit.

[audio:https://www.audiomedica.com/podcasting/global_health/070117rodger_macarthur.mp3]
Share

Tags: antiretroviralhivinhibitorsnucleosideproteasetranscriptase

You may also like...

  • David Schellenberg Bed-Nets To Prevent Malaria: Latest Research Evidence 20 Sep, 2011
  • Cathy Zimmerman Migrant Health: A Key Issue For Global Health 29 May, 2011
  • Blind For Blindness: Preventing Childhood Blindness Blind For Blindness: Preventing Childhood Blindness 28 May, 2008
  • Simon Brooker “This Wormy World”: Global Atlas of Worm Infections 18 Oct, 2010

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Telomere Length Predicts Coronary Heart Disease Risk and Statin Response
  • Next story Miscarriage Risk in Women with Low Body Mass Index
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • New Front Line Standard for Older Patients with…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT…
  • Home
  • Public Health
  • Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.